Latest IGCS News

Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer

SEOUL, South Korea -- Treatment with the bispecific antibody ubamatamab alone or

Derick Alison Derick Alison

T-DXd Tied to Encouraging Survival in HER2-Expressing Gyn Cancers

SEOUL, South Korea -- Durable responses with trastuzumab deruxtecan (T-DXd; Enhertu) in

Derick Alison Derick Alison

Sexual Health Suffered After Radical Hysterectomy for Early Cervical Cancer

SEOUL, South Korea -- Women with low-risk, early-stage cervical cancer who underwent

Derick Alison Derick Alison

Mixed Results for Tiragolumab/Atezolizumab Combo in PD-L1+ Recurrent Cervical Cancer

SEOUL, South Korea -- Combining the novel anti-TIGIT monoclonal antibody tiragolumab with

Derick Alison Derick Alison

RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancer

SEOUL, South Korea -- The combination of avutometinib and defactinib achieved "exceptionally"

Derick Alison Derick Alison

Maintenance Selinexor May Boost PFS in TP53 Wild-Type Advanced Endometrial Cancer

SEOUL, South Korea -- Maintenance therapy with selinexor (Xpovio) seemed to substantially

Derick Alison Derick Alison